| Genomic analyses identify molecular subtypes of pancreatic cancer P Bailey, DK Chang, K Nones, AL Johns, AM Patch, MC Gingras, ... Nature 531 (7592), 47-52, 2016 | 3416 | 2016 |
| Whole genomes redefine the mutational landscape of pancreatic cancer N Waddell, M Pajic, AM Patch, DK Chang, KS Kassahn, P Bailey, ... Nature 518 (7540), 495-501, 2015 | 2765 | 2015 |
| Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes AV Biankin, N Waddell, KS Kassahn, MC Gingras, LB Muthuswamy, ... Nature 491 (7424), 399-405, 2012 | 2259 | 2012 |
| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1972* | 2020 |
| Integrated genomic characterization of pancreatic ductal adenocarcinoma BJ Raphael, RH Hruban, AJ Aguirre, RA Moffitt, JJ Yeh, C Stewart, ... Cancer cell 32 (2), 185-203. e13, 2017 | 1711 | 2017 |
| Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer VP Balachandran, M Łuksza, JN Zhao, V Makarov, JA Moral, R Remark, ... Nature 551 (7681), 512-516, 2017 | 1070 | 2017 |
| Whole-genome landscape of pancreatic neuroendocrine tumours A Scarpa, DK Chang, K Nones, V Corbo, AM Patch, P Bailey, RT Lawlor, ... Nature 543 (7643), 65-71, 2017 | 918 | 2017 |
| Molecular subtypes of pancreatic cancer EA Collisson, P Bailey, DK Chang, AV Biankin Nature reviews Gastroenterology & hepatology 16 (4), 207-220, 2019 | 843 | 2019 |
| CXCR2 inhibition profoundly suppresses metastases and augments immunotherapy in pancreatic ductal adenocarcinoma CW Steele, SA Karim, JDG Leach, P Bailey, R Upstill-Goddard, L Rishi, ... Cancer cell 29 (6), 832-845, 2016 | 808 | 2016 |
| Interrogating open issues in cancer precision medicine with patient-derived xenografts AT Byrne, DG Alférez, F Amant, D Annibali, J Arribas, AV Biankin, A Bruna, ... Nature Reviews Cancer 17 (4), 254-268, 2017 | 696 | 2017 |
| Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide. AL Goldstein, TL Low, M McAdoo, J McClure, GB Thurman, J Rossio, ... Proceedings of the National Academy of Sciences 74 (2), 725-729, 1977 | 558 | 1977 |
| Margin clearance and outcome in resected pancreatic cancer DK Chang, AL Johns, ND Merrett, AJ Gill, EK Colvin, CJ Scarlett, ... Journal of Clinical Oncology 27 (17), 2855-2862, 2009 | 389 | 2009 |
| ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer RE Miller, A Leary, CL Scott, V Serra, CJ Lord, D Bowtell, DK Chang, ... Annals of Oncology 31 (12), 1606-1622, 2020 | 376 | 2020 |
| Macrophage-released pyrimidines inhibit gemcitabine therapy in pancreatic cancer CJ Halbrook, C Pontious, I Kovalenko, L Lapienyte, S Dreyer, HJ Lee, ... Cell metabolism 29 (6), 1390-1399. e6, 2019 | 375 | 2019 |
| The prognostic and predictive value of serum CA19. 9 in pancreatic cancer JL Humphris, DK Chang, AL Johns, CJ Scarlett, M Pajic, MD Jones, ... Annals of oncology 23 (7), 1713-1722, 2012 | 357 | 2012 |
| The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma PA Pérez-Mancera, AG Rust, L Van Der Weyden, G Kristiansen, A Li, ... Nature 486 (7402), 266-270, 2012 | 351 | 2012 |
| Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy BW Miller, JP Morton, M Pinese, G Saturno, NB Jamieson, E McGhee, ... EMBO molecular medicine 7 (8), 1063-1076, 2015 | 287 | 2015 |
| Genome‐wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT‐ROBO, ITGA2 and MET signaling K Nones, N Waddell, S Song, AM Patch, D Miller, A Johns, J Wu, ... International journal of cancer 135 (5), 1110-1118, 2014 | 253 | 2014 |
| Precision medicine for advanced pancreas cancer: the individualized molecular pancreatic cancer therapy (IMPaCT) trial LA Chantrill, AM Nagrial, C Watson, AL Johns, M Martyn-Smith, ... Clinical cancer research 21 (9), 2029-2037, 2015 | 242 | 2015 |
| Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma KM Mann, JM Ward, CCK Yew, A Kovochich, DW Dawson, MA Black, ... Proceedings of the National Academy of Sciences 109 (16), 5934-5941, 2012 | 240 | 2012 |
Nigel B JamiesonProfessor of Surgery and Consultant HPB Surgeon, Glasgow UniversityVerified email at glasgow.ac.uk
